Abstract
Currently, gene therapy is one of the most promising fields in biomedicine, with great therapeutic potential for an array of inherited and acquired diseases. Adeno-associated viral (AAV) vectors have emerged as promising tools to deliver selectively a therapeutic payload to target organs, including the heart. In this chapter, we describe the production and quality control of recombinant AAV (rAAV) vectors of the serotype 9, the most cardiotropic AAV serotype when delivered systemically in rodents. We also describe the systemic administration of rAAV vectors and the local delivery of rAAV vectors by direct intramyocardial injection. Taken together, the methods described in this chapter will allow the reader to deliver efficiently therapeutic genes to the rodent heart, both globally and regionally.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sonntag F, Schmidt K, Kleinschmidt JA (2010) A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc Natl Acad Sci U S A 107(22):10220–10225. https://doi.org/10.1073/pnas.1001673107
Kumaran N, Michaelides M, Smith AJ, Ali RR, Bainbridge JWB (2018) Retinal gene therapy. Br Med Bull. https://doi.org/10.1093/bmb/ldy005
Zincarelli C, Soltys S, Rengo G, Rabinowitz JE (2008) Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther 16(6):1073–1080. https://doi.org/10.1038/mt.2008.76
Moulay G, Ohtani T, Ogut O, Guenzel A, Behfar A, Zakeri R, Haines P, Storlie J, Bowen L, Pham L, Kaye D, Sandhu G, O’Connor M, Russell S, Redfield M (2015) Cardiac AAV9 gene delivery strategies in adult canines: assessment by long-term serial SPECT imaging of sodium iodide symporter expression. Mol Ther 23(7):1211–1221. https://doi.org/10.1038/mt.2015.78
Chamberlain K, Riyad JM, Weber T (2017) Cardiac gene therapy with adeno-associated virus-based vectors. 1Curr Opin Cardiol. https://doi.org/10.1097/HCO.0000000000000386
Samulski RJ, Muzyczka N (2014) AAV-mediated gene therapy for research and therapeutic purposes. Annu Rev Virol 1(1):427–451. https://doi.org/10.1146/annurev-virology-031413-085355
Snyder RO, Francis J (2005) Adeno-associated viral vectors for clinical gene transfer studies. Curr Gene Ther 5(3):311–321
Wright JF (2008) Manufacturing and characterizing AAV-based vectors for use in clinical studies. Gene Ther 15(11):840–848. https://doi.org/10.1038/gt.2008.65
Ayuso E, Mingozzi F, Bosch F (2010) Production, purification and characterization of adeno-associated vectors. Curr Gene Ther 10(6):423–436
Grimm D, Kern A, Rittner K, Kleinschmidt JA (1998) Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther 9(18):2745–2760
Wright JF (2009) Transient transfection methods for clinical adeno-associated viral vector production. Hum Gene Ther 20(7):698–706. https://doi.org/10.1089/hum.2009.064
Vandenberghe LH, Xiao R, Lock M, Lin J, Korn M, Wilson JM (2010) Efficient serotype-dependent release of functional vector into the culture medium during adeno-associated virus manufacturing. Hum Gene Ther 21(10):1251–1257. https://doi.org/10.1089/hum.2010.107
Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ, Muzyczka N (1999) Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 6(6):973–985. https://doi.org/10.1038/sj.gt.3300938
Zincarelli C, Soltys S, Rengo G, Koch WJ, Rabinowitz JE (2010) Comparative cardiac gene delivery of adeno-associated virus serotypes 1-9 reveals that AAV6 mediates the most efficient transduction in mouse heart. Clin Transl Sci 3(3):81–89. https://doi.org/10.1111/j.1752-8062.2010.00190.x
Watanabe S, Leonardson L, Hajjar RJ, Ishikawa K (2017) Cardiac gene delivery in large animal models: antegrade techniques. Methods Mol Biol 1521:227–235. https://doi.org/10.1007/978-1-4939-6588-5_16
Bonnet G, Ishikawa K, Hajjar RJ, Kawase Y (2017) Direct myocardial injection of vectors. Methods Mol Biol 1521:237–248. https://doi.org/10.1007/978-1-4939-6588-5_17
Hinkel R, Kupatt C (2017) Selective pressure-regulated retroinfusion for gene therapy application in ischemic heart disease. Methods Mol Biol 1521:249–260. https://doi.org/10.1007/978-1-4939-6588-5_18
Byrne MJ, Kaye DM (2017) Cardiac gene delivery using recirculating devices. Methods Mol Biol 1521:261–269. https://doi.org/10.1007/978-1-4939-6588-5_19
Katz MG, Fargnoli AS, Kendle AP, Bridges CR (2017) Molecular cardiac surgery with recirculating delivery (MCARD): procedure and vector transfer. Methods Mol Biol 1521:271–289. https://doi.org/10.1007/978-1-4939-6588-5_20
Federica del Monte KI, Roger J. Hajjar (2017) Gene transfer to rodent hearts in vivo. In: Ishikawa K (ed) Cardiac gene therapy: methods and protocols. Methods Mol Biol, vol 1521. Springer Science + Business Media, New York, pp 195–204. https://doi.org/10.1007/978-1-4939-6588-5_13
Speakman JR, Keijer J (2012) Not so hot: optimal housing temperatures for mice to mimic the thermal environment of humans. Mol Metab 2(1):5–9. https://doi.org/10.1016/j.molmet.2012.10.002
Garber JC, Wayne Barbee R, Bielitzki JT, Clayton LA, Donovan JC, Hendriksen CFM, Kohn DF, Lipman NS, Locke PA, Melcher J, Quimby FW, Turner PV, Wood GA, Wurbel H (2011) Environment, housing and management. In: Fletcher CH (ed) Guide for the care and use of laboratory animals, 8th edn. National Academy of Sciences, Washington, DC, pp 45–112
Turner PV, Pekow C, Vasbinder MA, Brabb T (2011) Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute preparation. J Am Assoc Lab Anim Sci 50(5):614–627
Yardeni T, Eckhaus M, Morris HD, Huizing M, Hoogstraten-Miller S (2011) Retro-orbital injections in mice. Lab Anim (NY) 40(5):155–160. https://doi.org/10.1038/laban0511-155
Kohlbrenner E, Weber T (2017) Production and characterization of vectors based on the cardiotropic AAV serotype 9. In: Ishikawa K (ed) Cardiac gene therapy: methods and protocols, vol 1521. Methods in molecular biology. Springer Science + Business Media, New York, pp 91–107
Aurnhammer C, Haase M, Muether N, Hausl M, Rauschhuber C, Huber I, Nitschko H, Busch U, Sing A, Ehrhardt A, Baiker A (2012) Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences. Hum Gene Ther Methods 23(1):18–28. https://doi.org/10.1089/hgtb.2011.034
Kohlbrenner E, Henckaerts E, Rapti K, Gordon RE, Linden RM, Hajjar RJ, Weber T (2012) Quantification of AAV particle titers by infrared fluorescence scanning of coomassie-stained sodium dodecyl sulfate-polyacrylamide gels. Hum Gene Ther Methods 23(3):198–203
Fagone P, Wright JF, Nathwani AC, Nienhuis AW, Davidoff AM, Gray JT (2012) Systemic errors in quantitative polymerase chain reaction titration of self-complementary adeno-associated viral vectors and improved alternative methods. Hum Gene Ther Methods 23(1):1–7. https://doi.org/10.1089/hgtb.2011.104
Gray JT, Zolotukhin S (2011) Design and construction of functional AAV vectors. Methods Mol Biol 807:25–46. https://doi.org/10.1007/978-1-61779-370-7_2
Gruntman AM, Su L, Su Q, Gao G, Mueller C, Flotte TR (2015) Stability and compatibility of recombinant adeno-associated virus under conditions commonly encountered in human gene therapy trials. Hum Gene Ther Methods 26(2):71–76. https://doi.org/10.1089/hgtb.2015.040
Turner PV, Brabb T, Pekow C, Vasbinder MA (2011) Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci 50(5):600–613
Steel CD, Stephens AL, Hahto SM, Singletary SJ, Ciavarra RP (2008) Comparison of the lateral tail vein and the retro-orbital venous sinus as routes of intravenous drug delivery in a transgenic mouse model. Lab Anim (NY) 37(1):26–32. https://doi.org/10.1038/laban0108-26
Pacher P, Nagayama T, Mukhopadhyay P, Batkai S, Kass DA (2008) Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 3(9):1422–1434. https://doi.org/10.1038/nprot.2008.138
Acknowledgments
We would like to thank Elena Chepurko, Malik Bisserier, and Anthony Fargnoli for helpful discussions. This work is supported by NIH P50 HL112324, R01 HL119046, R01 HL117505, R01 HL128099, R01 HL129814, R01 HL131404 and Trans-Atlantic Network of Excellence grants 13CVD01 and 14CVD03 from the Leducq Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Lopez-Gordo, E., Kohlbrenner, E., Katz, M.G., Weber, T. (2019). AAV Vectors for Efficient Gene Delivery to Rodent Hearts. In: Castle, M. (eds) Adeno-Associated Virus Vectors. Methods in Molecular Biology, vol 1950. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9139-6_19
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9139-6_19
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9138-9
Online ISBN: 978-1-4939-9139-6
eBook Packages: Springer Protocols